| Ident. | Authors (with country if any) | Title |
|---|
| 000023 |
Kelly Bertram [Australie] ; David R. Williams [Australie] | Visual hallucinations in the differential diagnosis of parkinsonism |
| 000048 |
Manu Sharma ; John P A. Ioannidis [États-Unis] ; Jan O. Aasly [Norvège] ; Grazia Annesi [Italie] ; Alexis Brice [France] ; Lars Bertram [Allemagne] ; Maria Bozi [Grèce] ; Maria Barcikowska [Pologne] ; David Crosiers [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Maurizio F. Facheris ; Matthew Farrer [Canada] ; Gaetan Garraux ; Suzana Gispert [Allemagne] ; Georg Auburger ; Carles Vilari O-Güell [Canada] ; Georgios M. Hadjigeorgiou [Grèce] ; Andrew A. Hicks ; Nobutaka Hattori [Japon] ; Beom S. Jeon [Corée du Sud] ; Zygmunt Jamrozik [Pologne] ; Anna Krygowska-Wajs [Pologne] ; Suzanne Lesage [France] ; Christina M. Lill [Grèce, Allemagne] ; Juei-Jueng Lin [Taïwan] ; Timothy Lynch [Irlande (pays)] ; Peter Lichtner [Allemagne] ; Anthony E. Lang [Canada] ; Cecile Libioulle [Canada] ; Miho Murata [Japon] ; Vincent Mok [Hong Kong] ; Barbara Jasinska-Myga [Pologne] ; George D. Mellick [Australie] ; Karen E. Morrison [Royaume-Uni] ; Thomas Meitnger [Allemagne] ; Alexander Zimprich [Autriche] ; Grzegorz Opala [Allemagne] ; Peter P. Pramstaller ; Irene Pichler ; Sung Sup Park [Allemagne] ; Aldo Quattrone [Italie] ; Ekaterina Rogaeva [Canada] ; Owen A. Ross [États-Unis] ; Leonidas Stefanis [Grèce] ; Joanne D. Stockton [Royaume-Uni] ; Wataru Satake [Japon] ; Peter A. Silburn [Australie] ; Tim M. Strom [Allemagne, Canada] ; Jessie Theuns [Belgique] ; Eng- King Tan [Singapour] ; Tatsushi Toda [Japon] ; Hiroyuki Tomiyama [Japon] ; Ryan J. Uitti [États-Unis] ; Christine Van Broeckhoven [Belgique] ; Karin Wirdefeldt ; Zbigniew Wszolek [États-Unis] ; Georgia Xiromerisiou [Grèce] ; Harumi S. Yomono [Japon] ; Kuo-Chu Yueh [Taïwan] ; Yi Zhao ; Thomas Gasser ; Demetrius Maraganore [États-Unis] ; Rejko Krüger | A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants |
| 000063 |
Gregory L. Willis [Australie] ; Cleo Moore [Australie] ; Stuart M. Armstrong [Australie] | Breaking away from dopamine deficiency: an essential new direction for Parkinson’s disease |
| 000086 |
W G J. Reid [Australie] ; M A Hely [Australie] ; J G L. Morris [Australie] ; C. Loy [Australie] ; G M Halliday [Australie] | Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study) |
| 000092 |
Michael Eller [Australie] ; David R. Williams | α-Synuclein in Parkinson disease and other neurodegenerative disorders |
| 000097 |
James M. Shine [Australie] ; Glenda M. Halliday [Australie] ; Sharon L. Naismith [Australie] ; Simon J. G. Lewis [Australie] | Visual misperceptions and hallucinations in Parkinson's disease: Dysfunction of attentional control networks? |
| 000102 |
Samantha A. Hollingworth [Australie] ; Amanda Rush [Australie] ; Wayne D. Hall [Australie] ; Mervyn J. Eadie [Australie] | Utilization of anti‐Parkinson drugs in Australia: 1995–2009 |
| 000112 |
Gabriella Constantinescu [Australie] ; Deborah Theodoros [Australie] ; Trevor Russell [Australie] ; Elizabeth Ward [Australie] ; Stephen Wilson [Australie] ; Richard Wootton [Royaume-Uni] | Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non‐inferiority trial |
| 000185 |
Jamie M. Sheard ; Susan Ash [Australie] ; Peter A. Silburn [Australie] ; Graham K. Kerr [Australie] | Prevalence of malnutrition in Parkinson's disease: a systematic review |
| 000227 |
Sharon L. Naismith [Australie] ; Zoë Terpening [Australie] ; James M. Shine [Australie] ; Simon J. G. Lewis [Australie] | Neuropsychological functioning in Parkinson's disease: Differential relationships with self‐reported sleep‐wake disturbances |
| 000237 |
Alison Kan [Australie] ; Michael C. Dove [Australie] ; Wayne A. O'Connor [Australie] ; Sham V. Nair [Australie] ; David A. Raftos [Australie] | Mortality in single‐pair mating families of QX disease‐resistant and wild‐type Sydney rock oysters (Saccostrea glomerata) |
| 000253 |
Glenda Halliday [Australie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Matthew Stern [États-Unis] | Milestones in Parkinson's disease—Clinical and pathologic features |
| 000287 |
Alexis Elbaz [France] ; Owen A. Ross [États-Unis] ; John P. A. Ioannidis [Grèce, États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Frédéric Moisan [France] ; Jan Aasly [Norvège] ; Grazia Annesi [Italie] ; Maria Bozi [Grèce] ; Laura Brighina [Italie] ; Marie-Christine Chartier-Harlin [France] ; Alain Destée [France] ; Carlo Ferrarese [Italie] ; Alessandro Ferraris [Italie] ; J. Mark Gibson [Irlande (pays)] ; Suzana Gispert [Allemagne] ; Georgios M. Hadjigeorgiou [Grèce] ; Barbara Jasinska-Myga [Pologne] ; Christine Klein [Allemagne] ; Rejko Krüger [Allemagne] ; Jean-Charles Lambert [France] ; Katja Lohmann [Allemagne] ; Simone Van De Loo [Allemagne] ; Marie-Anne Loriot [France] ; Timothy Lynch [Irlande (pays)] ; George D. Mellick [Australie] ; Eugénie Mutez [France] ; Christer Nilsson [Suède] ; Grzegorz Opala [Pologne] ; Andreas Puschmann [Suède] ; Aldo Quattrone [Italie] ; Manu Sharma [Allemagne] ; Peter A. Silburn [Australie] ; Leonidas Stefanis [Grèce] ; Ryan J. Uitti [États-Unis] ; Enza Maria Valente [Italie] ; Carles Vilari O-Güell [États-Unis, Canada] ; Karin Wirdefeldt [Suède] ; Zbigniew K. Wszolek [États-Unis] ; Georgia Xiromerisiou [Grèce] ; Demetrius M. Maraganore [États-Unis] ; Matthew J. Farrer [États-Unis, Canada] | Independent and joint effects of the MAPT and SNCA genes in Parkinson disease |
| 000291 |
Polly Ambermoon [Australie] ; Adrian Carter [Australie] ; Wayne D. Hall [Australie] ; Nadeeka N. W. Dissanayaka [Australie] ; John D. O'Sullivan [Australie] | Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field |
| 000303 |
Glenda M. Halliday [Australie] ; Claire H. Stevens [Australie] | Glia: Initiators and progressors of pathology in Parkinson's disease |
| 000321 |
Mehrnaz Shoushtarian [Australie] ; Anna Murphy [Australie] ; Robert Iansek [Australie] | Examination of central gait control mechanisms in Parkinson's disease using movement‐related potentials |
| 000331 |
Y. J. Zhao [Singapour] ; L. C. S. Tan ; S. C. Li [Singapour, Australie] ; W. L. Au ; S. H. Seah ; P. N. Lau ; N. Luo [Singapour] ; H. L. Wee [Singapour] | Economic burden of Parkinson’s disease in Singapore |
| 000350 |
Emma C. Schofield [Australie] ; John R. Hodges [Australie] ; Virginia Macdonald [Australie] ; Nicholas J. Cordato [Australie] ; Jillian J. Kril [Australie] ; Glenda M. Halliday [Australie] | Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy |
| 000365 |
Yun Ju Christine Song [Australie] ; Yue Huang [Australie] ; Glenda Margaret Halliday [Australie] | Clinical correlates of similar pathologies in parkinsonian syndromes |
| 000388 |
Natalie E. Allen [Australie] ; Catherine Sherrington [Australie] ; Serene S. Paul [Australie] ; Colleen G. Canning [Australie] | Balance and falls in Parkinson's disease: A meta‐analysis of the effect of exercise and motor training |
| 000411 |
Kitty K. Wong [Australie] ; Jane E. Alty [Australie] ; Amanda G. Goy [Australie] ; Sanjay Raghav [Australie] ; David C. Reutens [Australie] ; Peter A. Kempster [Australie] | A randomized, double‐blind, placebo‐controlled trial of levetiracetam for dyskinesia in Parkinson's disease |
| 000429 |
Deborah Lehmann [Australie] ; Judith Willis [Australie] ; Hannah C. Moore [Australie] ; Carolien Giele [Australie] ; Denise Murphy [Australie] ; Anthony D. Keil [Australie] ; Catherine Harrison [Australie] ; Kathy Bayley [Australie] ; Michael Watson [Australie] ; Peter Richmond [Australie] | The Changing Epidemiology of Invasive Pneumococcal Disease in Aboriginal and Non-Aboriginal Western Australians from 1997 through 2007 and Emergence of Nonvaccine Serotypes |
| 000504 |
Tom H. Johnston [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Juha-Matti Savola [Suisse] ; Jonathan M. Brotchie [Canada] | The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates |
| 000512 |
Glenda Margaret Halliday [Australie] ; Heather Mccann [Australie] | The progression of pathology in Parkinson's disease |
| 000577 |
Ying Jiao Zhao ; Hwee Lin Wee ; Yiong-Huak Chan ; Soo Hoon Seah ; Wing Lok Au ; Puay Ngoh Lau ; Emmanuel Camara Pica ; Shu Chuen Li [Australie] ; Nan Luo ; Louis C. S. Tan | Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times |
| 000622 |
Evangelos Evangelou [Grèce, Suisse] ; Demetrius M. Maraganore [États-Unis] ; Grazia Annesi [Italie] ; Laura Brighina [Italie] ; Alexis Brice [France] ; Alexis Elbaz [France] ; Carlo Ferrarese [Italie] ; Georgios M. Hadjigeorgiou [Grèce] ; Rejko Krueger [Allemagne] ; Jean-Charles Lambert [France] ; Suzanne Lesage [France] ; Katerina Markopoulou [Grèce] ; George D. Mellick [Australie] ; Bram Meeus [Belgique] ; Nancy L. Pedersen [Suède] ; Aldo Quattrone [Italie] ; Christine Van Broeckhoven [Belgique] ; Manu Sharma [Allemagne] ; Peter A. Silburn [Australie] ; Eng-King Tan [Singapour] ; Karin Wirdefeldt [Suède] ; John P. A. Ioannidis [Grèce, États-Unis] | Non‐replication of association for six polymorphisms from meta‐analysis of genome‐wide association studies of Parkinson's disease: Large‐scale collaborative study |
| 000681 |
Sean S. O'Sullivan [Royaume-Uni] ; Atbin Djamshidian [Royaume-Uni, Autriche] ; Zeshan Ahmed [Royaume-Uni] ; Andrew H. Evans [Australie] ; Andrew D. Lawrence [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Impulsive‐compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy |
| 000713 |
Kay Seidel [Allemagne] ; Ludger Schöls [Allemagne] ; Silke Nuber [Allemagne] ; Elisabeth Petrasch-Parwez [Allemagne] ; Kristin Gierga [Allemagne] ; Zbigniew Wszolek [États-Unis] ; Dennis Dickson [États-Unis] ; Wei P. Gai [Australie] ; Antje Bornemann [Allemagne] ; Olaf Riess [Allemagne] ; Abdelhaq Rami [Allemagne] ; Wilfried F. A. Den Dunnen [Pays-Bas] ; Thomas Deller [Allemagne] ; Udo Rüb [Allemagne] ; Rejko Krüger [Allemagne] | First appraisal of brain pathology owing to A30P mutant alpha‐synuclein |
| 000770 |
Andrew H. Evans [Australie, Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Silke Appel Cresswell [Canada] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni] | Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward |
| 000807 |
Gabriella Constantinescu [Australie] ; Deborah Theodoros [Australie] ; Trevor Russell [Australie] ; Elizabeth Ward [Australie] ; Stephen Wilson [Australie] ; Richard Wootton [Royaume-Uni] | Assessing disordered speech and voice in Parkinson's disease: a telerehabilitation application |
| 000814 |
Nadeeka N. W. Dissanayaka [Australie] ; Anna Sellbach [Australie] ; Sally Matheson [Australie] ; John D. O'Sullivan [Australie] ; Peter A. Silburn [Australie] ; Gerard J. Byrne [Australie] ; Rodney Marsh [Australie] ; George D. Mellick [Australie] | Anxiety disorders in Parkinson's disease: Prevalence and risk factors |
| 000830 |
Lukasz Szumowski [Pologne] ; Ewa Szufladowicz [Pologne] ; Michał Orczykowski [Pologne] ; Robert Bodalski [Pologne] ; Paweł Derejko [Pologne] ; Andrzej Przybylski [Pologne] ; Piotr Urbanek [Pologne] ; Mariusz Ku Mierczyk [Pologne] ; Edward Ko Luk [Pologne] ; Frederic Sacher [France] ; Prashanthan Sanders [Australie] ; Joanna Dangel [Pologne] ; Michel Haissaguerre [France] ; Franciszek Walczak [Pologne] | Ablation of Severe Drug‐Resistant Tachyarrhythmia During Pregnancy |
| 000832 |
M. Kaye Trembath [Australie] ; Zoë A. Horton [Australie] ; Lynette Tippett [Nouvelle-Zélande] ; Virginia Hogg [Nouvelle-Zélande] ; Veronica R. Collins [Australie] ; Andrew Churchyard [Australie] ; Dennis Velakoulis [Australie] ; Richard Roxburgh [Nouvelle-Zélande] ; Martin B. Delatycki [Australie] | A retrospective study of the impact of lifestyle on age at onset of Huntington disease |
| 000841 |
Barry J. Snow [Nouvelle-Zélande] ; Fiona L. Rolfe [Nouvelle-Zélande] ; Michelle M. Lockhart [Nouvelle-Zélande] ; Christopher M. Frampton [Nouvelle-Zélande] ; John D. O'Sullivan [Australie] ; Victor Fung [Australie] ; Robin A. J. Smith [Nouvelle-Zélande] ; Michael P. Murphy [Royaume-Uni] ; Kenneth M. Taylor [Nouvelle-Zélande] | A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's disease |
| 000886 |
Rachel Chee [Australie] ; Anna Murphy [Australie] ; Mary Danoudis [Australie] ; Nellie Georgiou-Karistianis [Australie] ; Robert Iansek [Australie] | Gait freezing in Parkinson's disease and the stride length sequence effect interaction |
| 000905 |
Mark D. Latt ; Hylton B. Menz ; Victor S. Fung ; Stephen R. Lord [Australie] | Acceleration Patterns of the Head and Pelvis During Gait in Older People With Parkinson's Disease: A Comparison of Fallers and Nonfallers |
| 000906 |
M. Selikhova [Royaume-Uni, Russie] ; D. R. Williams [Royaume-Uni, Australie] ; P. A. Kempster [Royaume-Uni, Australie] ; J. L. Holton [Royaume-Uni] ; T. Revesz [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | A clinico-pathological study of subtypes in Parkinson's disease |
| 000930 |
Laura Silveira-Moriyama [Royaume-Uni] ; Aviva Petrie [Royaume-Uni] ; David R. Williams [Australie] ; Andrew Evans [Australie] ; Regina Katzenschlager [Autriche] ; Egberto R. Barbosa [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] | The use of a color coded probability scale to interpret smell tests in suspected parkinsonism |
| 000973 |
Linda Truong [Australie] ; Daniel Brooks [Australie] ; Fabricio Amaral [Australie] ; Jasmine M. Henderson [Australie] ; Glenda M. Halliday [Australie] | Relative preservation of thalamic centromedian nucleus in parkinsonian patients with dystonia |
| 000A32 |
Prachi Mehta [Australie] ; George D. Mellick [Australie] ; Dominic B. Rowe [Australie] ; Glenda M. Halliday [Australie] ; Michael M. Jones [Australie] ; Neil Manwaring [Australie] ; Himesha Vandebona [Australie] ; Peter A. Silburn [Australie] ; Jie Jin Wang [Australie] ; Paul Mitchell [Australie] ; Carolyn M. Sue [Australie] | Mitochondrial DNA haplogroups J and K are not protective for Parkinson's disease in the Australian community |
| 000A62 |
Andrew H. Evans [Australie] ; Antonio P. Strafella [Canada] ; Daniel Weintraub [États-Unis] ; Mark Stacy [États-Unis] | Impulsive and compulsive behaviors in Parkinson's disease |
| 000A71 |
Greg T. Sutherland [Australie] ; Gerhard A. Siebert [Australie] ; Jeremy R. B. Newman [Australie] ; Peter A. Silburn [Australie] ; Richard S. Boyle [Australie] ; John D. O'Sullivan [Australie] ; George D. Mellick [Australie] | Haplotype analysis of the PARK 11 gene, GIGYF2, in sporadic Parkinson's disease |
| 000A76 |
Ming-Jen Lee [Taïwan] ; Ignacio F. Mata [États-Unis] ; Chin-Hsien Lin [Taïwan] ; Kai-Yuan Tzen [Taïwan] ; Sarah J. Lincoln [États-Unis] ; Rebecca Bounds [États-Unis] ; Paul J. Lockhart [Australie] ; Mary M. Hulihan [États-Unis] ; Matthew J. Farrer [États-Unis] ; Ruey-Meei Wu [Taïwan] | Genotype–phenotype correlates in Taiwanese patients with early‐onset recessive parkinsonism |
| 000B10 |
Rogan B. Tinsley [Australie] ; Chris R. Bye [Australie] ; Clare L. Parish [Australie] ; Angela Tziotis-Vais [Australie] ; Sonia George [Australie] ; Janetta G. Culvenor [Australie] ; Qiao-Xin Li [Australie] ; Colin L. Masters [Australie] ; David I. Finkelstein [Australie] ; Malcolm K. Horne [Australie] | Dopamine D2 receptor knockout mice develop features of Parkinson disease |
| 000B11 |
Greg T. Sutherland [Australie] ; Glenda M. Halliday [Australie] ; Peter A. Silburn [Australie] ; Frank L. Mastaglia [Australie] ; Dominic B. Rowe [Australie] ; Richard S. Boyle [Australie] ; John D. O'Sullivan [Australie] ; Tina Ly [Australie] ; Steve D. Wilton [Australie] ; George D. Mellick [Australie] | Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease? |
| 000B27 |
Mario Congiu ; Maurice L. Mashford ; John L. Slavin [Australie] ; Paul V. Desmond | Coordinate regulation of metabolic enzymes and transporters by nuclear transcription factors in human liver disease |
| 000B43 |
A H Evans [Australie, Royaume-Uni] ; A D Lawrence [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson’s disease |
| 000B77 |
Meg E. Morris [Australie] ; Robert Iansek [Australie] ; Beth Kirkwood [Australie] | A randomized controlled trial of movement strategies compared with exercise for people with Parkinson's disease |
| 000C53 |
Mariese A. Hely [Australie] ; Wayne G. J. Reid [Australie] ; Michael A. Adena [Australie] ; Glenda M. Halliday [Australie] ; John G. L. Morris [Australie] | The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years |
| 000C91 |
Linton J. Meagher [Australie] ; Ralf Ilchef [Australie] ; Paul Silberstein [Australie] ; Raymond J. Cook [Australie] ; Daniel Wasson [Australie] ; Gin S. Malhi [Australie] | Psychiatric morbidity in patients with Parkinson’s disease following bilateral subthalamic deep brain stimulation: literature review |
| 000D28 |
Sean S. O'Sullivan [Royaume-Uni] ; David R. Williams [Royaume-Uni, Australie] ; David A. Gallagher [Royaume-Uni] ; Luke A. Massey [Royaume-Uni] ; Laura Silveira-Moriyama [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Nonmotor symptoms as presenting complaints in Parkinson's disease: A clinicopathological study |
| 000D72 |
Shen-Yang Lim [Canada] ; Andrew H. Evans [Australie] ; Janis M. Miyasaki [Canada] | Impulse Control and Related Disorders in Parkinson's Disease |
| 000D77 |
Christopher F. Mcnicoll [États-Unis] ; Jeanne C. Latourelle [États-Unis] ; Marcy E. Macdonald [États-Unis] ; Mark F. Lew [États-Unis] ; Oksana Suchowersky [Canada] ; Christine Klein [Allemagne] ; Lawrence I. Golbe [États-Unis] ; Margery H. Mark [États-Unis] ; John H. Growdon [États-Unis] ; G. Frederick Wooten [États-Unis] ; Ray L. Watts [États-Unis] ; Mark Guttman [Canada] ; Brad A. Racette [États-Unis] ; Joel S. Perlmutter [États-Unis] ; Anwar Ahmed [États-Unis] ; Holly A. Shill [États-Unis] ; Carlos Singer [États-Unis] ; Marie H. Saint-Hilaire [États-Unis] ; Tiffany Massood [États-Unis] ; Karen W. Huskey [États-Unis] ; Anita L. Destefano [États-Unis] ; Tammy Gillis [États-Unis] ; Jayalakshmi Mysore [États-Unis] ; Stefano Goldwurm [Italie] ; Gianni Pezzoli [Italie] ; Kenneth B. Baker [États-Unis] ; Ilia Itin [États-Unis] ; Irene Litvan [États-Unis] ; Garth Nicholson [Australie] ; Alastair Corbett [Australie] ; Martha Nance [États-Unis] ; Edward Drasby [États-Unis] ; Stuart Isaacson [États-Unis] ; David J. Burn [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] ; Peter P. Pramstaller [Italie] ; Jomana Al-Hinti [États-Unis] ; Anette T. Moller [Danemark] ; Karen Ostergaard [Danemark] ; Scott J. Sherman [États-Unis] ; Richard Roxburgh [Nouvelle-Zélande] ; Barry Snow [Nouvelle-Zélande] ; John T. Slevin [États-Unis] ; Franca Cambi [États-Unis] ; James F. Gusella [États-Unis] ; Richard H. Myers [États-Unis] | Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study |
| 000D86 |
Greg Sutherland [Australie] ; George Mellick [Australie] ; Jeremy Newman [Australie] ; Kay L. Double [Australie] ; Julia Stevens [Australie] ; Linda Lee [Australie] ; Dominic Rowe [Australie] ; Peter Silburn [Australie] ; Glenda M. Halliday [Australie] | Haplotype analysis of the IGF2‐INS‐TH gene cluster in Parkinson's disease |
| 000D94 |
Meg E. Morris [Australie] ; Robert Iansek [Australie] ; Brook Galna [Australie] | Gait festination and freezing in Parkinson's disease: Pathogenesis and rehabilitation |
| 000D97 |
Aileen K. Ho [Royaume-Uni] ; John L. Bradshaw [Australie] ; Robert Iansek [Australie] | For better or worse: The effect of levodopa on speech in Parkinson's disease |
| 000D98 |
Frances Huxham [Australie] ; Richard Baker [Australie] ; Meg E. Morris [Australie] ; Robert Iansek [Australie] | Footstep adjustments used to turn during walking in Parkinson's disease |
| 000E02 |
Y. J. Zhao [Singapour] ; L. C. S. Tan [Singapour] ; P. N. Lau [Singapour] ; W. L. Au [Singapour] ; S. C. Li [Australie] ; N. Luo [Singapour] | Factors affecting health‐related quality of life amongst Asian patients with Parkinson’s disease |
| 000E14 |
Richard Cordell [Australie] ; Hoe C. Lee [Australie] ; Andrew Granger [Australie] ; Barry Vieira [Australie] ; Andy H. Lee [Australie] | Driving assessment in Parkinson's disease—A novel predictor of performance? |
| 000E18 |
Shen-Yang Lim [Australie] ; Michael J. Farrell [Australie] ; Stephen J. Gibson [Australie] ; Robert D. Helme [Australie] ; Anthony E. Lang [Canada] ; Andrew H. Evans [Australie] | Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease? |
| 000E67 |
Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Cristina Sampaio [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Apathy and anhedonia rating scales in Parkinson's disease: Critique and recommendations |
| 000E68 |
Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Christina Sampaio [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Anxiety rating scales in Parkinson's disease: Critique and recommendations |
| 000F83 |
Yue Huang [Australie] ; Glenda M. Halliday [Australie] ; Himesha Vandebona [Australie] ; George D. Mellick [Australie] ; Frank Mastaglia [Australie] ; Julia Stevens [Australie] ; John Kwok [Australie] ; Michael Garlepp [Australie] ; Peter A. Silburn [Australie] ; Malcolm K. Horne [Australie] ; Katya Kotschet [Australie] ; Alison Venn [Australie] ; Dominic B. Rowe [Australie] ; Justin P. Rubio [Australie] ; Carolyn M. Sue [Australie] | Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's Disease |
| 000F88 |
P. Mehta [Australie] ; A. Kifley [Australie] ; J. J. Wang [Australie] ; E. Rochtchina [Australie] ; P. Mitchell [Australie] ; C. M. Sue [Australie] | Population prevalence and incidence of Parkinson’s disease in an Australian community |
| 001047 |
Julian P. Rodrigues [Australie] ; Susan E. Walters [Australie] ; Peter Watson [Australie] ; Rick Stell [Australie] ; Frank L. Mastaglia [Australie] | Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson's disease |
| 001075 |
Bruno Dubois [France] ; David Burn [Royaume-Uni] ; Christopher Goetz [États-Unis] ; Dag Aarsland [Norvège] ; Richard G. Brown [Royaume-Uni] ; Gerald A. Broe [Australie] ; Dennis Dickson [États-Unis] ; Charles Duyckaerts [France] ; Jefferey Cummings [États-Unis] ; Serge Gauthier [Canada] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Yoshikuni Mizuno [Japon] ; Ian G. Mckeith [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Murat Emre [Turquie] | Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force |
| 001080 |
Anette Schrag [Royaume-Uni] ; Paolo Barone [Italie] ; Richard G. Brown [Royaume-Uni] ; Albert F. G. Leentjens [Pays-Bas] ; William M. Mcdonald [États-Unis] ; Sergio Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Depression rating scales in Parkinson's disease: Critique and recommendations |
| 001098 |
Murat Emre [Turquie] ; Dag Aarsland [Norvège] ; Richard Brown [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Charles Duyckaerts [France] ; Yoshikino Mizuno [Japon] ; Gerald Anthony Broe [Australie] ; Jeffrey Cummings [États-Unis] ; Dennis W. Dickson [États-Unis] ; Serge Gauthier [Canada] ; Jennifer Goldman [États-Unis] ; Christopher Goetz [États-Unis] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Ian Mckeith [Royaume-Uni] ; Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; Christina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Bruno Dubois [France] | Clinical diagnostic criteria for dementia associated with Parkinson's disease |
| 001137 |
Ruth M. Pickering [Royaume-Uni] ; Yvette A. M. Grimbergen [Pays-Bas] ; Una Rigney [Royaume-Uni] ; Ann Ashburn [Royaume-Uni] ; Gordon Mazibrada [Royaume-Uni] ; Brian Wood [Royaume-Uni] ; Peggy Gray [Canada] ; Graham Kerr [Australie] ; Bastiaan R. Bloem [Pays-Bas] | A meta‐analysis of six prospective studies of falling in Parkinson's disease |
| 001143 |
Robert Menzies [Australie] ; Peter Mcintyre | Vaccine Preventable Diseases and Vaccination Policy for Indigenous Populations |
| 001175 |
Peter Sutton-Smith [Australie] ; Ian H. Parkinson [Australie] ; Andrew M. J. Linn [Australie] ; Simone A. Kooke [Australie] ; Nicola L. Fazzalari [Australie] | Trabecular rod buckling index in thoraco‐lumbar vertebral bone |
| 001179 |
Robert Iansek [Australie] ; Frances Huxham [Australie] ; Jennifer Mcginley [Australie] | The sequence effect and gait festination in Parkinson disease: Contributors to freezing of gait? |
| 001281 |
A. Cagnin [Italie] ; M. Kassiou [Australie] ; S. R. Meikle [Australie] ; R. B. Banati [Australie] | In vivo evidence for microglial activation in neurodegenerative dementia |
| 001306 |
Jess Nithianantharajah [Australie] ; Anthony J. Hannan [Australie] | Enriched environments, experience-dependent plasticity and disorders of the nervous system |
| 001397 |
Farah Feeney [Australie] ; Sarah Egan [Australie] ; Gasson [Australie] | Treatment of depression and anxiety in Parkinson's Disease: A pilot study using group cognitive behavioural therapy |
| 001402 |
Meg Morris [Australie] ; Robert Iansek [Australie] ; Jennifer Mcginley [Australie] ; Thomas Matyas [Australie] ; Frances Huxham [Australie] | Three‐dimensional gait biomechanics in Parkinson's disease: Evidence for a centrally mediated amplitude regulation disorder |
| 001412 |
Mariese A. Hely [Australie] ; John G. L. Morris [Australie] ; Wayne G. J. Reid [Australie] ; Robert Trafficante [Australie] | Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years |
| 001434 |
L. Wang [Australie] ; H. Yang [Australie] ; Y. Zhang [Australie] | Recurrence of symptomatic atrial fibrillation after successful catheter ablation of atrioventricular accessory pathways: a multivariate regression analysis |
| 001445 |
Ross Corkrey [Royaume-Uni] ; Lynne Parkinson [Australie] ; Lucy Bates [Australie] ; Sue Green [Australie] ; Aye Thidar Htun [Australie] | Pilot of a novel cervical screening intervention: interactive voice response |
| 001491 |
John B. J. Kwok [Australie] ; Marianne Hallupp [Australie] ; Clement T. Loy [Australie] ; Daniel K. Y. Chan [Australie] ; Jean Woo [République populaire de Chine] ; George D. Mellick ; Daniel D. Buchanan ; Peter A. Silburn ; Glenda M. Halliday [Australie] ; Peter R. Schofield [Australie] | GSK3B polymorphisms alter transcription and splicing in Parkinson's disease |
| 001515 |
Grant A. Mackenzie [Australie] ; Jonathan R. Carapetis [Australie] ; Peter S. Morris [Australie] ; Amanda Jane Leach | Current issues regarding the use of pneumococcal conjugate and polysaccharide vaccines in Australian children |
| 001516 |
Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Hughes [Australie] ; Andrew Evans [Royaume-Uni] ; Alice J. Manson [Royaume-Uni] ; Marion Hoffman [Australie] ; Lesley Swinn [Royaume-Uni] ; Hilary Watt [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challenges |
| 001567 |
P. K. Panegyres [Australie] | The contribution of the study of neurodegenerative disorders to the understanding of human memory |
| 001570 |
John B. J. Kwok ; Erdahl T. Teber ; Clement Loy ; Marianne Hallupp ; Garth Nicholson [Australie] ; George D. Mellick [Australie] ; Daniel D. Buchanan [Australie] ; Peter A. Silburn [Australie] ; Peter R. Schofield | Tau haplotypes regulate transcription and are associated with Parkinson's disease |
| 001601 |
Kevin J. Barnham [Australie] ; Colin L. Masters [Australie] ; Ashley I. Bush [Australie, États-Unis] | Neurodegenerative diseases and oxidative stress |
| 001623 |
Antony J. Harding [Australie] ; Anurina Das [Australie] ; Jillian J. Kril [Australie] ; William S. Brooks [Australie] ; David Duffy [Australie] ; Glenda M. Halliday [Australie] | Identification of families with cortical Lewy body disease |
| 001639 |
Claire E. Heise [Australie] ; John Mitrofanis [Australie] | Evidence for a glutamatergic projection from the zona incerta to the basal ganglia of rats |
| 001721 |
Frank L. Mastaglia [Australie] ; Russell D. Johnsen [Australie] ; Michelle L. Byrnes [Australie] ; Byron A. Kakulas [Australie] | Prevalence of amyloid‐β deposition in the cerebral cortex in Parkinson's disease |
| 001731 |
Sofia A. Oliveira [États-Unis] ; William K. Scott [États-Unis] ; Eden R. Martin [États-Unis] ; Martha A. Nance [États-Unis] ; Ray L. Watts [États-Unis] ; Jean P. Hubble [États-Unis] ; William C. Koller [États-Unis] ; Rajesh Pahwa [États-Unis] ; Matthew B. Stern [États-Unis] ; Bradley C. Hiner [États-Unis] ; William G. Ondo [États-Unis] ; Fred H. Allen Jr. [États-Unis] ; Burton L. Scott [États-Unis] ; Christopher G. Goetz [États-Unis] ; Gary W. Small [États-Unis] ; Frank Mastaglia [Australie] ; Jeffrey M. Stajich [États-Unis] ; Fengyu Zhang [États-Unis] ; Michael W. Booze [États-Unis] ; Michelle P. Winn [États-Unis] ; Lefkos T. Middleton [Royaume-Uni] ; Jonathan L. Haines [États-Unis] ; Margaret A. Pericak-Vance [États-Unis] ; Jeffery M. Vance [États-Unis] | Parkin mutations and susceptibility alleles in late‐onset Parkinson's disease |
| 001816 |
Simon G. Parkin [Royaume-Uni] ; Ralph P. Gregory [Royaume-Uni] ; Richard Scott [Royaume-Uni] ; Peter Bain [Royaume-Uni] ; Peter Silburn [Australie] ; Bruce Hall [Australie] ; Richard Boyle [Australie] ; Carole Joint [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni] | Unilateral and bilateral pallidotomy for idiopathic Parkinson's disease: A case series of 115 patients |
| 001837 |
Virginia Macdonald [Australie] ; Glenda M. Halliday [Australie] | Selective loss of pyramidal neurons in the pre‐supplementary motor cortex in Parkinson's disease |
| 001929 |
Djf Christie ; Dj Coleman ; X. Wan ; Ma Jacobs ; Jr Carapetis [Australie] | Childhood invasive pneumococcal disease in Tasmania, 1994−2000 |
| 001952 |
Meg E. Morris [Australie] ; Frances Huxham [Australie] ; Jennifer Mcginley [Australie] ; Karen Dodd [Australie] ; Robert Iansek [Australie] | The biomechanics and motor control of gait in Parkinson disease |
| 001971 |
Peter Davey [Australie, Niger] ; Narayan Rajan [Australie] ; Michael Lees [Australie] ; Michael Aristides [Australie] | Cost-Effectiveness of Pergolide Compared to Bromocriptine in the Treatment of Parkinson's Disease: A Decision-Analytic Model |
| 001993 |
Anne Evans-Murray [Australie] | Wolff Parkinson White (WPW) syndrome: what the critical care nurse needs to consider when administering antiarrhythmics |
| 001A96 |
Paul J. Spira [Australie] ; David M. Sharpe [Australie] ; Glenda Halliday [Australie] ; Julie Cavanagh [Australie] ; Garth A. Nicholson [Australie] | Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr α‐synuclein mutation |
| 001B42 |
Peter K. Panegyres [Australie] ; K. Zafiris-Toufexis [Australie] ; B. A. Kakulas [Australie] | Amyloid precursor protein gene isoforms in Alzheimer’s disease and other neurodegenerative disorders |
| 001B52 |
Rhonda J. Holmes [Australie] ; Jennifer M. Oates [Australie] ; Debbie J. Phyland [Australie] ; Andrew J. Hughes [Australie] | Voice characteristics in the progression of Parkinson's disease |
| 001B55 |
Mariese A. Hely [Australie] ; Victor S. C. Fung [Australie] ; John G. L. Morris [Australie] | Treatment of Parkinson's disease |
| 001C00 |
Louise M. Waite [Australie] ; G. Anthony Broe [Australie] ; David A. Grayson [Australie] ; Helen Creasey [Australie] | Motor function and disability in the dementias |
| 001C10 |
J. M. Henderson [Australie] ; K. Carpenter [Australie] ; H. Cartwright [Australie] ; G. M. Halliday [Australie] | Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications |
| 001C27 |
Jaqueline M. Bond [Australie] ; Meg Morris [Australie] | Goal-directed secondary motor tasks: Their effects on gait in subjects with Parkinson disease |
| 001C63 |
Heiko Braak [Allemagne] ; Kelly Del Tredici [Allemagne] ; Wei Ping Gai [Australie] ; Eva Braak [Allemagne] | Alpha-synuclein is not a requisite component of synaptic boutons in the adult human central nervous system |
| 001C74 |
Aileen K. Ho [Australie] ; John L. Bradshaw [Australie] ; Robert Iansek [Australie] ; Robin Alfredson [Australie] | Speech volume regulation in Parkinson’s disease: effects of implicit cues and explicit instructions |
| 001D62 |
Ross Cunnington [Australie] ; Robert Iansek [Australie] ; John L. Bradshaw [Australie] | Movement‐related potentials in Parkinson's disease: External cues and attentional strategies |
| 001E59 |
John M. Power [Australie] ; Graham A. Beacom [Australie] ; Cue A. Aleerness [États-Unis] ; Jai Raman [Australie] ; Maurits Wueeels [Pays-Bas] ; Stephen J. Earish [Australie] ; Louise M. Burrell [Australie] ; Andrew M. Tonkin [Australie] | Susceptibility to Atrial Fibrillation: |
| 001E96 |
John D. O'Sullivan [Australie] ; Catherine M. Said [Australie] ; Louise C. Dillon [Australie] ; Marion Hoffman [Australie] ; Hughes [Australie] | Gait analysis in patients with Parkinson's disease and motor fluctuations: Influence of levodopa and comparison with other measures of motor function |
| 001E98 |
N. L Fazzalari [Australie] ; I. H Parkinson [Australie] | Fractal Properties of Cancellous Bone of the Iliac Crest in Vertebral Crush Fracture |
| 001E99 |
Nicola L. Fazzalari [Australie] ; Ian H. Parkinson [Australie] | Femoral Trabecular Bone of Osteoarthritic and Normal Subjects in an Age and Sex Matched Group |
| 001F29 |
Michael L. Selley [Australie] | (E)-4-Hydroxy-2-Nonenal May be Involved in the Pathogenesis of Parkinson’s Disease |
| 001F37 |
Kenneth Opeskin [Australie] ; Ross Mcd Anderson [Australie] | Suspected MPTP-induced parkinsonism |
| 001F55 |
Judie Walton [Australie] | Handwriting changes due to aging and Parkinson's syndrome |
| 001F87 |
D. A. Mcritchie [Australie] ; H. R. Cartwright [Australie] ; G. M. Halliday [Australie] | Specific A10 Dopaminergic Nuclei in the Midbrain Degenerate in Parkinson's Disease |
| 002006 |
Colleen G. Canning [Australie] ; Jennifer A. Alison [Australie] ; Natalie E. Allen [Australie] ; Herbert Groeller [Australie] | Parkinson's disease: An investigation of exercise capacity, respiratory function, and gait |
| 002045 |
Peter R. Dodd [Australie] ; Allison L. Eckert [Australie] ; Linda M. Fletcher [Australie] ; Jillian J. Kril [Australie] ; Clive G. Harper [Australie] ; June W. Halliday [Australie] | Concentrations of transferrin and carbohydrate‐deficient transferrin in postmortem human brain from alcoholics |
| 002076 |
Meg E. Morris ; Robert Iansek ; Thomas A. Matyas ; Jeffery J. Summers [Australie] | Stride length regulation in Parkinson's disease |
| 002078 |
G. Parkinson [Australie] ; B. H Thorp [Royaume-Uni] ; J. Azuolas [Australie] ; S. Vaiano [Australie] | Sequential studies of endochondral ossification and serum 1,25-dihydroxycholecalciferol in broiler chickens between one and 21 days of age |
| 002101 |
Ross Cunnington [Australie] ; Robert Iansek [Australie] ; Gary W. Thickbroom [Australie] ; Bev A. Laing [Australie] ; Frank L. Mastaglia [Australie] ; John L. Bradshaw [Australie] ; Jim G. Phillips [Australie] | Effects of magnetic stimulation over supplementary motor area on movement in Parkinson's disease |
| 002102 |
M. J. Wright [Australie] ; G. M. Geffen [Australie] ; L. B. Geffen [Australie] | ERP measures of stimulus processing during an auditory oddball task in Parkinson's disease: Evidence for an early information processing deficit |
| 002104 |
Meg E. Morris [Australie] ; Robert Iansek [Australie] | Characteristics of motor disturbance in Parkinson's disease and strategies for movement rehabilitation |
| 002110 |
M. A Hely [Australie] ; J. G. L Morris [Australie] ; R. J Burns [Australie] ; C. M Lander [Australie] ; D. B Mclaughlin [Australie] ; G. A Donnan [Australie] | An Australian multicentre open label study of pergolide as an adjunct to levodopa in Parkinson's disease |
| 002116 |
Wayne G. J Reid [Australie] ; Mariese A. Hely [Australie] ; John G. L Morris [Australie] ; Gerald A. Broe [Australie] ; Michael Adena [Australie] ; Dudley J. O Sullivan [Australie] ; Peter M. Williamson [Australie] | A longitudinal of Parkinson's disease: clinical and neuropsychological correlates of dementia |
| 002174 |
S. Agar [Australie] ; A. Gay [Australie] ; C. Gallagher [Australie] ; R. Steele ; P. Spencer [Australie] | Glucose-6-phosphate dehydrogenase and oxidant sensitivity of erythrocytes of three species of wombats |
| 002177 |
N. L. Fazzalari [Australie] ; I. H. Parkinson [Australie] | FRACTAL DIMENSION AND ARCHITECTURE OF TRABECULAR BONE |
| 002215 |
W. P. Gai [Australie] ; W. W. Blessing [Australie] ; P. C. Blumbergs [Australie] | Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease |
| 002218 |
Keree M. B. Bennett ; Maurizio Marchetti ; Roberto Iovine ; Umberto Castiello [Australie] | The drinking action of Parkinson's disease subjects |
| 002235 |
Ross Cunnington [Australie] ; Robert Iansek [Australie] ; John L. Bradshaw ; Jim G. Phillips | Movement-related potentials in Parkinson's disease |
| 002446 |
P. A. Kempster [Australie] ; M. L. Wahlqvist [Australie] | Dietary Factors in the Management of Parkinson's Disease |
| 002482 |
M. J. Wright ; G. M. Geffen [Australie] ; L. B. Geffen [Australie] | Event-related potentials associated with covert orientation of visual attention in Parkinson's disease |
| 002531 |
G. Phillips [Australie] ; L. Bradshaw [Australie] ; R. Iansek [Australie] ; E. Chiu [Australie] | Motor functions of the basal ganglia |
| 002536 |
Gai [Australie] ; Geffen [Australie] ; L. Denoroy [France] ; W. W. Blessing [Australie] | Loss of C1 and C3 epinephrine‐synthesizing neurons in the medulla oblongata in parkinson's disease |
| 002596 |
M. H. Sharpe [Australie] | Auditory attention in early Parkinson's disease: An impairment in focused attention |
| 002659 |
W. P. Gai ; G. M. Halliday ; P. C. Blumbergs [Australie] ; L. B. Geffen ; W. W Blessing | SUBSTANCE P-CONTAINING NEURONS IN THE MESOPONTINE TEGMENTUM ARE SEVERELY AFFECTED IN PARKINSON'S DISEASE |
| 002677 |
D. V. Cousins [Australie] ; G. M. Robertson [Australie] ; J. Parkinson [Australie] ; R. B. Richards [Australie] | Use of the Enzyme Linked Immunosorbent Assay (ELISA) to Detect the IgM and IgG Antibody Response to Leptospira interrogans Serovar hardjo in Pregnant Ewes |
| 002704 |
A. Donnan [Australie] ; G. Woodhouse [Australie] ; J. Kaczmarczyk [Australie] ; E. Holder [Australie] ; G. Paxinos [Australie] ; J. Chilco [Australie] ; J. Churchyard [Australie] ; M. Kalnins [Australie] ; A. Fabinyi [Australie] ; O. Mendelsohn [Australie] | Evidence for plasticity of the dopaminergic system in Parkinsonism |
| 002743 |
M. J. Wright [Australie] ; R. J. Burns [Australie] ; G. M. Geffen [Australie] ; L. B. Geffen [Australie] | Covert orientation of visual attention in Parkinson's disease: An impairment in the maintenance of attention |
| 002764 |
G. M. Halliday [Australie] ; Y. W. Li [Australie] ; P. C. Blumbergs [États-Unis] ; T. H. Joh [Australie] ; R. G. H. Cotton [Australie] ; P. R. C. Howe [Australie] ; W. W. Blessing [Australie] ; L. B. Geffen [Australie] | Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease |
| 002802 |
Frini Karayanidis [Australie] | Parkinson's disease: A conceptualization of neuropsychological deficits within an information-processing framework |
| 002916 |
K. Mcginnes [Australie] ; J. Florence [Australie] ; R. Penny [Australie] | The effect of radiotherapy on the natural killer (NK)-cell activity of cancer patients |
| 002A75 |
Andres M. Salazar [États-Unis] ; Colin L. Masters [Australie] ; D. Carleton Gajdusek [États-Unis] ; Clarence J. Gibbs Jr [États-Unis] | Syndromes of amyotrophic lateral sclerosis and dementia: Relation to transmissible Creutzfeldt‐Jakob disease |
| 002B12 |
D. Richards [Australie] ; A. Denniss [Australie] ; P. Russell [Australie] ; D. Johnson [Australie] ; N. Buchanan [Australie] ; C. Whight [Australie] ; A. Chong ; J. Utherf [Australie] | Surgical Division of Right and Left Free Wall Accessory Atrioventricular Electrical Connections in a Child with Incessant Supraventricular Tachycardia |
| 002B46 |
A. Tonkin [Australie] | Recognition and Management of Supraventricular Tachyarrhythmias |
